The Study of Long-Term Deterioration of Kidney Transplants.

This study is not yet open for participant recruitment.

Verified by Mayo Clinic, September 2005

Sponsors and Collaborators:	Mayo Clinic National Institutes of Health (NIH) Hennepin County Medical Center - Minneapolis University of Alabama at Birmingham University of Alberta University of Iowa
Information provided by:	Mayo Clinic
ClinicalTrials.gov Identifier:	NCT00217126

Purpose

This study is being done to create a kidney transplant database with information from many transplant centers for the purpose of studying ways to help improve transplant outcomes and the care of transplant recipients. This is also being done to learn why kidney transplant recipients have worsening of their kidney function, and whether there are specific findings that could result in future treatments.

Condition	Phase
Kidney Transplant Recipients	Phase IV

MedlinePlus related topics: Kidney Transplantation

U.S. FDA Resources

Study Type:	Observational
Official Title:	Long-Term Kidney Function (2 Arms-Prospective and Retrospective)

Further study details as provided by Mayo Clinic:

Estimated Enrollment:	2000
Study Start Date:	September 2005

Detailed Description:

Data will be collected from the participant's medical records, local health care providers and participant's to clarify or add any information. Participants will have samples of blood, and urine obtained during their routine visits, that will be saved for testing in this study. In addition, participant's receiving a kidney biopsy performed as a part of their clinical care, will have a piece of the biopsy used for the study. This study will be followed for five years.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

In the prospective group, all participants who will be receiving a kidney transplant are eligible. In the retrospective group, kidney transplant recipients who are undergoing a kidney biopsy to determine the cause of change in their serum creatine level.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00217126

Locations

United States, Minnesota
Mayo Clinic
Rochester, Minnesota, United States, 55905

Sponsors and Collaborators

Mayo Clinic

National Institutes of Health (NIH)

Hennepin County Medical Center - Minneapolis

University of Alabama at Birmingham

University of Alberta

University of Iowa

Investigators

Principal Investigator:

Fernando G. Cosio, M.D.

Mayo Clinic

More Information

Study ID Numbers:	143-05
Study First Received:	September 16, 2005
Last Updated:	December 20, 2007
ClinicalTrials.gov Identifier:	NCT00217126
Health Authority:	United States: Institutional Review Board

ClinicalTrials.gov processed this record on January 14, 2009